Avanti Biosciences is a private biotechnology company located in Long Island (New York) and focused on the discovery and development of innovative therapies for patients with debilitating diseases. Our strategy is to develop efficient form of therapies designed to control complex diseases via new chemical entities (NCE) derived from natural products by making them more bioavailable and selective.
Avanti's scientific founders are internationally recognized in the field of drug discovery and clinical development. They have exceptional track record in identifying and translating new research into breakthrough science and therapeutics.
The scientific discoveries of Avanti Biosciences have also the potential for applications in a wide range of other therapeutic indications including cancer, allergy, and inflammation.
Company Details
- Founded
- -
- Address
- 25 Health Sciences Dr., Stony Brook,ny 11790,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.avantibiosciences.com
- HQ
- Stony Brook, NY
Avanti Biosciences, Inc. Questions
Avanti Biosciences, Inc.'s website is http://www.avantibiosciences.com
Avanti Biosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/avanti-biosciences
Avanti Biosciences, Inc.'s industry is
Biotechnology Research
Avanti Biosciences, Inc.'s top competitors are
Invitreo Biosciences Pte Ltd,
Inlighta Biosciences Llc,
Terra Bioforge,
Sivec Biotechnologies Llc,
Plakous Therapeutics,
Rebel Medicine,
Epigentek,
Yaso Therapeutics Inc.,
Zbeats Inc.,
7 Hills Pharma.
Avanti Biosciences, Inc.'s categories are Biotechnology Research
Avanti Biosciences, Inc.'s founding year is 2009
